{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:08:01Z","timestamp":1782256081213,"version":"3.54.5"},"reference-count":46,"publisher":"Impact Journals, LLC","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,5,3]]},"DOI":"10.18632\/oncotarget.8524","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T10:42:52Z","timestamp":1459507372000},"page":"26454-26464","source":"Crossref","is-referenced-by-count":12,"title":["Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer. Do stem cell like cells predict prognosis?"],"prefix":"10.18632","volume":"7","author":[{"given":"Issam","family":"Chebouti","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Hospital Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Blassl","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Hospital D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Wimberger","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Carl-Gustav-Carus University, TU Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Neubauer","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Hospital D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Fehm","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Hospital D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Kimmig","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Hospital Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Kasimir-Bauer","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Hospital Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1002\/cncr.11349","article-title":"Incidence of ovarian cancer by race, ethnicity in the United States, 1992-1997","volume":"97","author":"Chen","year":"2003","journal-title":"Cancer"},{"key":"2","first-page":"42","article-title":"Future options for first-line therapy of advanced ovarian cancer","volume":"1","author":"Pfisterer","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)","volume":"115","author":"Pfisterer","year":"2009","journal-title":"Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2007.02.026","article-title":"Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)","volume":"106","author":"Du Bois","year":"2007","journal-title":"Gynecol Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1245\/s10434-010-0964-9","article-title":"Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group)","volume":"17","author":"du Bois","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"6","first-page":"105269","article-title":"Cancer stem cells and epithelial ovarian cancer","volume":"2010","author":"Dafou","year":"2010","journal-title":"J Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13577-010-0002-z","article-title":"Clinical significance of side population in ovarian cancer cells","volume":"24","author":"Ishizuka","year":"2011","journal-title":"Hum Cell"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Boesch, Zeimet, Reimer, Schmidt, Parson, Spoeck, Hatina, Wolf, Sopper. The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics. 2014; 5:7027\u201339.","DOI":"10.18632\/oncotarget.2053"},{"key":"9","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1158\/0008-5472.CAN-04-3931","article-title":"Stem and Progenitor-Like Cells Contribute to the Aggressive Behavior of Human Epithelial Ovarian Cancer","volume":"65","author":"Kurrey","year":"2005","journal-title":"Cancer Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/onc.2009.500","article-title":"Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer","volume":"29","author":"Huang","year":"2010","journal-title":"Oncogene"},{"key":"11","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1158\/0008-5472.CAN-12-4177","article-title":"SOX2 expression associates with stem cell state in human ovarian carcinoma","volume":"73","author":"Fehm","year":"2013","journal-title":"Cancer Res"},{"key":"12","first-page":"358","article-title":"SOX2 in ovarian carcinoma - association with high grade and improved outcome after platinum-based chemotherapy","volume":"32","author":"Kanz","year":"2013","journal-title":"Int J Gynecol Pathol"},{"key":"13","first-page":"e9959414","article-title":"SOX2 Enhances the Migration and Invasion of Ovarian Cancer Cells via Src Kinase","volume":"9","author":"Feng","year":"2014","journal-title":"PLoS One"},{"key":"14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1089\/omi.2013.0058","article-title":"SOX2 targets fibronectin 1 to promote cell migration and invasion in ovarian cancer: new molecular leads for therapeutic intervention","volume":"17","author":"Lin","year":"2013","journal-title":"OMICS"},{"key":"15","doi-asserted-by":"crossref","first-page":"9823","DOI":"10.1007\/s13277-015-3561-5","article-title":"Overexpression of SOX2 is involved in paclitaxel resistance of ovarian cancer via the PI3K\/Akt pathway","volume":"36","author":"Ren","year":"2015","journal-title":"Tumour Biol"},{"key":"16","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12885-015-1553-x","article-title":"Overexpression of Class III \u03b2-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer","volume":"15","author":"Wang","year":"2015","journal-title":"BMC Cancer"},{"key":"17","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/IGC.0b013e3181a23c4c","article-title":"Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies","volume":"19","author":"Fehm","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1200\/JCO.2001.19.2.368","article-title":"Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse","volume":"19","author":"Pantel","year":"2001","journal-title":"J Clin Oncol"},{"key":"19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ygyno.2014.03.016","article-title":"Circulating and disseminated tumor cells in ovarian cancer: A systematic review","volume":"133","author":"Diaz-Padilla","year":"2014","journal-title":"Gynecol Oncol"},{"key":"20","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/IGC.0b013e3182907109","article-title":"Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer","volume":"23","author":"Kasimir-Bauer","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13048-015-0168-9","article-title":"Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2015","journal-title":"Journal of Ovarian Research"},{"key":"22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2007.07.073","article-title":"Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer","volume":"107","author":"Kasimir-Bauer","year":"2007","journal-title":"Gynecol. Oncol"},{"key":"23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/cncr.10250","article-title":"Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis","volume":"94","author":"Fodstad","year":"2002","journal-title":"Cancer"},{"key":"24","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0090-8258(90)90088-3","article-title":"Bone marrow involvement in epithelial ovarian cancer by immunocytochemical assessment","volume":"38","author":"Livingston","year":"1990","journal-title":"Gynecol Oncol"},{"key":"25","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ejca.2010.02.030","article-title":"Cancer stemness and metastasis: therapeutic consequences and perspectives","volume":"46","author":"Fodde","year":"2010","journal-title":"Eur J Cancer"},{"key":"26","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1158\/1078-0432.CCR-06-0169","article-title":"Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype","volume":"12","author":"Cote","year":"2006","journal-title":"Clin Cancer Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.ejca.2011.01.011","article-title":"Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44CD24lo cancer stem cell phenotype","volume":"47","author":"Woodward","year":"2011","journal-title":"Eur J Cancer"},{"key":"28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00432-010-0867-y","article-title":"Expression of Sox2 in human ovarian epithelial carcinoma","volume":"137","author":"Chen","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ng.392","article-title":"Lin28 promotes transformation and is associated with advanced human malignancies","volume":"41","author":"Mermel","year":"2009","journal-title":"Nat Genet"},{"key":"30","doi-asserted-by":"crossref","first-page":"9823","DOI":"10.1007\/s13277-015-3561-5","article-title":"Overexpression of Sox2 is involved in paclitaxel resistance of ovarian cancer via the PI3K\/AKT pathway","volume":"36","author":"Ren","year":"2015","journal-title":"Tumour Biol"},{"key":"31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12885-015-1553-x","article-title":"Overexpression of Class III \u00df-tubulin, Sox2, and nuclear surviving is predictive of taxane resistance in patients with stage III ovarian epithelial cancer","volume":"15","author":"Wang","year":"2015","journal-title":"BMC Cancer"},{"key":"32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0009-2797(80)90122-2","article-title":"Kinetic analysis of thebinding of radioactive cis-and trans-dichlorodiammineplatinum (II) to DNA","volume":"30","author":"Rahn","year":"1980","journal-title":"Chem Biol Interact"},{"key":"33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1634\/theoncologist.4-2-87","article-title":"Extending the Platinum-free Interval in Recurrent Ovarian Cancer: The role of Topeka in Second-Line Chemotherapy","volume":"4","author":"Bookman Michael","year":"1999","journal-title":"The Oncologist"},{"key":"34","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanism of cisplatin resistance","volume":"31","author":"Kroemer","year":"2012","journal-title":"Oncogene"},{"issue":"10","key":"35","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1373\/clinchem.2014.224808","article-title":"ERCC1-positive circulating tumor cells in the blood of Ovarian cancer patients as a predictive biomarker for platinum resistance","volume":"60","author":"Kasimir-Bauer","year":"2014","journal-title":"Clinical Chemistry"},{"key":"36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ctrv.2011.11.001","article-title":"Epithelial-mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact","volume":"38","author":"Giovanna","year":"2012","journal-title":"Cancer treatment Reviews"},{"key":"37","doi-asserted-by":"crossref","first-page":"abstr e11514","DOI":"10.1200\/jco.2011.29.15_suppl.e11514","article-title":"Effects of an mTOR inhibitor RAD001 on human breast cancer stem cellsand","volume":"29","author":"Zhang","year":"2011","journal-title":"J Clin Oncol"},{"key":"38","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of selective inhibitors of cancer stem cells by high-throughput screening","volume":"138","author":"Lander","year":"2009","journal-title":"Cell"},{"key":"39","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1007\/s12010-015-1696-x","article-title":"A novel approach for overcoming drug Resistance in breast cancer chemotherapy by targeting new synthetic curcumin analogues against aldehyde dehydrogenase 1 (ALDH1A1) and glycogen synthase kinase-3 \u00df (GSK-3\u00df)","volume":"176","author":"Misra","year":"2015","journal-title":"Appl Biochem Biotechnol"},{"key":"40","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/stem.2039","article-title":"targeting cancer stem cells using immunologic approaches","volume":"33","author":"Wicha","year":"2015","journal-title":"Stem Cells"},{"key":"41","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nrc3153","article-title":"Novel cancer immunotherapy agents with survival benefit: Recent successes and next steps","volume":"11","author":"Allison","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"42","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Antonia","year":"2012","journal-title":"N Engl J Med"},{"key":"43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004347-200001000-00003","article-title":"Histopathologic grading of ovarian carcinoma: a review and proposal","volume":"19","author":"Silverberg","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"44","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/cncr.22076","article-title":"A concept for the standardized detection of disseminated tumor cells in bone marrow of patients with primary breast cancer and its clinical implementation","volume":"107","author":"Solomayer","year":"2006","journal-title":"Cancer"},{"key":"45","first-page":"377","article-title":"Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. Establishment of objective criteria for the evaluation of immunostained cells: The European ISHAGE Working Group for Standardization of Tumor Cell Detection","volume":"5","author":"Marolleau","year":"1999","journal-title":"Cytotherapy"},{"issue":"87","key":"46","first-page":"1","article-title":"CD34: structure, biology, and clinical utility","volume":"1","author":"May","year":"1996","journal-title":"Blood"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T16:07:58Z","timestamp":1594829278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":46,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2016,5,3]]}},"alternative-id":["8524","27049920"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8524","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,1]]}}}